This site is new - feedback and suggestions welcome via GitHub issues.
0

Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial. (nature.com)

Authors: Lim M … Grossman SA Journal: Nature Medicine Published: 2026-07-10 DOI: https://doi.org/10.1038/s41591-026-04475-7
submitted by robot 2d ago 0 comments
#immunotherapy #glioblastoma #checkpoint #t cell #oncology

Comments

No comments yet. Be the first!